{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:28:19Z","timestamp":1761560899348},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2004,6,18]],"date-time":"2004-06-18T00:00:00Z","timestamp":1087516800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1007\/s00330-004-2367-4","type":"journal-article","created":{"date-parts":[[2004,6,19]],"date-time":"2004-06-19T04:59:07Z","timestamp":1087621147000},"page":"2020-2024","source":"Crossref","is-referenced-by-count":11,"title":["Percutaneous placement of peritoneal port-catheter in oncologic patients"],"prefix":"10.1007","volume":"14","author":[{"given":"Franco","family":"Orsi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo Della","family":"Vigna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Penco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Lovati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Bellomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,6,18]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0305-7372(86)90007-1","volume":"13","author":"Markman","year":"1986","unstructured":"Markman M (1986) Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity. Cancer Treat Rev 13:219?242","journal-title":"Cancer Treat Rev"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0277-5379(90)90137-I","volume":"26","author":"Los","year":"1990","unstructured":"Los G, Mc Vie GJ (1990) Experimental and clinical status of intraperitoneal chemotherapy. Eur J Cancer 26:755?762","journal-title":"Eur J Cancer"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","volume":"335","author":"Alberts","year":"1996","unstructured":"Alberts DS, Liu PY, Hannigan EV et al (1996) Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus cyclophosphamide for stage III ovarian cancer. N Engl J Med 335:1950?1955","journal-title":"N Engl J Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/BF00177053","volume":"19","author":"Paganelli","year":"1992","unstructured":"Paganelli G, Belloni C, Magnani P, Zito F, Pasini A et al (1992) Two-step tumour targetting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidin. Eur J Nucl Med 19:322?329","journal-title":"Eur J Nucl Med"},{"key":"CR5","first-page":"858","volume":"154","author":"Jenkins","year":"1982","unstructured":"Jenkins J, Sugarbaker PH, Gianola FJ et al (1982) Technical considerations in the use of intraperitoneal chemotherapy administered by Tenckhoff catheter. Surg Gynecol Obstet 154:858?864","journal-title":"Surg Gynecol Obstet"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1006\/gyno.1994.1141","volume":"53","author":"Waggoner","year":"1994","unstructured":"Waggoner SE, Johnson J, Barter J et al (1994) Intraperitoneal therapy administered through a Groshong catheter. Gynecol Oncol 53:320?325","journal-title":"Gynecol Oncol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/gyno.1994.1161","volume":"54","author":"Malmstrom","year":"1994","unstructured":"Malmstrom H, Cartensen J, Simonsen E (1994) Experience with implanted subcutaneous ports for intraperitoneal chemotherapy in ovarian cancer. Gynecol Oncol 54:27?34","journal-title":"Gynecol Oncol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0090-8258(89)90009-7","volume":"35","author":"Pleiffer","year":"1989","unstructured":"Pleiffer P, Asmussen L, Kvist-Poulsen HY et al (1989) Intraperitoneal chemotherapy: introduction of a new ?single-use? delivery system?a preliminary report. Gynecol Oncol 35:47?49","journal-title":"Gynecol Oncol"},{"key":"CR9","first-page":"75","volume":"17","author":"Almadores","year":"1990","unstructured":"Almadores L, Yerys C (1990) Problems associated with the administration of intraperitoneal therapy using Porth-A Cath system. Oncol Nurs Forum 17(1):75?80","journal-title":"Oncol Nurs Forum"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0090-8258(86)90083-1","volume":"25","author":"Braly","year":"1986","unstructured":"Braly P, Doroshow J, Hoff S (1986) Technical aspects of intraperitoneal chemotherapy in abdominal carcinomatosis. Gynecol Oncol 25:319?333","journal-title":"Gynecol Oncol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1055\/s-2008-1066650","volume":"114","author":"Laffer","year":"1989","unstructured":"Laffer U, Durig M, Bloch HR et al (1989) Implatierbarte Katheter-systeme-Erfahrungen bei 205 Patienten. Dtsch Med Wochenschr 114:655?658","journal-title":"Dtsch Med Wochenschr"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/1096-9098(200007)74:3<223::AID-JSO14>3.0.CO;2-Q","volume":"74","author":"Topuz","year":"2000","unstructured":"Topuz E, Salihoglu Y, Aydiner A et al (2000) Celsite\ufffd Port and Catheter as an intraperitoneal access device in the treatment of ovarian cancer. J Surg Oncol 74:223?226","journal-title":"J Surg Oncol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/1097-0142(20010901)92:5<1204::AID-CNCR1439>3.0.CO;2-9","volume":"92","author":"Biffi","year":"2001","unstructured":"Biffi R, De Braud F, Orsi F, Pozzi S et al (2001) A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer 92:1204?1212","journal-title":"Cancer"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-004-2367-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-004-2367-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-004-2367-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:52:10Z","timestamp":1559029930000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-004-2367-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,18]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["2367"],"URL":"https:\/\/doi.org\/10.1007\/s00330-004-2367-4","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,18]]}}}